Day: December 13, 2024

VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”, “Rakovina”, or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies is pleased to announce the closing of a $3.0 million private placement. The private placement consists of 50,000,000 units (the “Units”) at a price of $0.06 per Unit. Each Unit consists of one common share of the Company (each, a “Common Share”) and one Common Share purchase warrant (each, a “Warrant”). Each Warrant entitles the holder thereof to subscribe for and purchase one Common Share of the Company for a period of 24 months from the date of issue at a price of $0.10 per Common Share. Rakovina retains the right to accelerate the Warrant exercise period...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN | OTCQB: GURFF | FRA: Q3J) (the “Company”) is pleased to announce a non-brokered flow-through private placement for gross proceeds of up to C$1,500,000 (the “Offering”). The Offering is expected to consist of the offering of units of the Company at a price of $0.75 per unit (each, a “Unit”), with each Unit comprised of one flow-through common share of the Company (each, a “FT Share”) and one-half of one non-flow-through common share (“Share”) purchase warrant of the Company (each, a “Warrant”), with each whole Warrant entitling the holder to acquire one Share in the capital of the Company (each, a “Warrant Share”) at a price of C$0.95 per...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES(All figures in Canadian dollars unless otherwise stated) TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd (TSXV: QGR, OTC: QGLDF, FRA: QX9G) (“Q-Gold” or the “Company”) is pleased to announce that it has closed a first tranche of previously announced non-brokered flow-through and non-flow through private placement (the “Offering”) for gross proceeds of C$503,406.28 (the “First Tranche”). Under the First Tranche, the Company issued (a) 2,200,000 flow-through units at $0.16 per unit (the “FT Units”), each FT Unit consisting of one flow-through common share (the “FT Shares”) and one-half of a warrant, each whole warrant exercisable at $0.20 per share for 24 months (the “FT Warrants”) and (b) 1,078,902 non-flow through units...

UNLOXCYT is the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), today announced that the U.S. Food and Drug Administration (“FDA”) has approved UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or curative radiation. UNLOXCYT is the first and only programmed death ligand-1 (“PD-L1”) blocking antibody to receive FDA marketing approval for this indication. The recommended commercial dosage of UNLOXCYT is 1,200 mg administered as an intravenous infusion over 60 minutes every three weeks. “Today’s FDA approval of UNLOXCYT – the first marketing...

Canada’s most efficient natural gas combined cycle facility generating reliable, affordable and cleaner power EDMONTON, Alberta, Dec. 13, 2024 (GLOBE NEWSWIRE) — Capital Power Corporation (TSX: CPX) is proud to announce its Genesee Repowering project is now complete as Genesee Unit 2 achieved combined cycle commercial operations today, resulting in Genesee Units 1 and 2 becoming Canada’s most efficient natural gas combined cycle facility. Completion of this industry-leading project increases overall capacity at the Genesee Generating Station by 512 megawatts (MW) and reduces CO2 emissions by 3.4 million tonnes annually – representing a ~60% increase in capacity while reducing emissions by ~40%. “Our Genesee Repowering project is immensely impactful for North American power generation, demonstrating there is a valuable life after...